Table 1.
Patient demographics
| Patient demographics | All | CD | UC | IBD type unknown |
|---|---|---|---|---|
| 132 | 65 (49%) | 63 (48%) | 4 (3%) | |
| Gender | ||||
| Sex (male) | 58 (44%) | 29 (45%) | 27 (43%) | 2 (50%) |
| Age | ||||
| Median (range) | 37 (18–85) | 43 (18–79) | 59 (18–85) | 30 (26–82) |
| Flare in last 6 months | ||||
| No | 52 (38%) | 27 (40%) | 24 (38%) | 1 (20%) |
| Yes | 80 (61%) | 38 (58%) | 39 (62%) | 3 (75%) |
| Current medication | ||||
| 5-ASA | 79 (60%) | 28 (43%) | 50 (79%) | 1 (25%) |
| Steroids | 20 (15%) | 8 (12%) | 12 (19%) | 0 |
| Thiopurine | 56 (42%) | 29 (45%) | 27 (43%) | 0 |
| Anti-TNFα | 31 (23%) | 25 (38%) | 6 (10%) | 0 |
| Methotrexate | 5 (4%) | 4 (6%) | 1 (2%) | 0 |
| Surgery | ||||
| Yes | 49 (37%) | 37 (57%) | 11 (17%) | 1 (25%) |
| Stoma | 10 (8%) | 5 (8%) | 5 (8%) | 0 |
ASA, aminosalicylic acid (mesalazine); CD, chrohn's disease; IBD, Inflammatory bowel disease; UC, ulcerative colitis.